Regeneron Pharmaceuticals Inc (REGN) Stock Price Today
Aura AI Summary
Key Stats
- $70.47BMarket Cap
- -Volume
- HealthSector
- $812.2752W High
- $545.4652W Low
- -Typical Hold Time
- $64.42BEnterprise Value
- 0.56%Div Yield
- -Trading Activity
Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $545.46 and a high of $812.27, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Most Recent News
3M shares jump 10% after beating Q2 earnings and raising full-year EPS forecast
3M reported strong Q2 2026 results with EPS of $2.40 beating estimates of $2.27 and revenue of $6.5 billion surpassing expectations. The 2.4% revenue growth was driven by a 5.4% rise in organic sales and strategic pricing. The company raised its full...

Global operating costs surge in Q2 amid Middle East conflict, but economic confidence shows slight recovery.
The Q2 2026 Global Economic Conditions Survey by ACCA and IMA reveals a sharp rise in operating costs for accountants and CFOs worldwide, driven by the Middle East conflict, soaring commodity prices, and supply chain issues. Over 75% of accountants a...

Argus Research raises Palo Alto Networks price target to $425 on booming AI-driven cybersecurity demand.
Argus Research increased its price target for Palo Alto Networks from $320 to $425, signaling a 25.66% potential upside. This boost reflects strong demand for cybersecurity services amid rising AI-related cyberattack concerns. The global cybersecurit...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.